Novel Radiopharmaceutical Beats Cabazitaxel in mCRPC
A novel radiopharmaceutical was more active than cabazitaxel against metastatic castration-resistant prostate cancer (mCRPC) and caused fewer grade 3/4 adverse …
Home ยป
Rituximab Likely Well-Tolerated in Pediatric Patients, but Infections Are Common
NEW YORK (Reuters Health) – Rituximab seemed to be well tolerated in children and adolescents in a retrospective study, but …